EUVIMEDEUVIMED entdecken
Crossref

Biologic targeted therapy in allergic asthma

Kevin Kron, Mason J. Crow, Ali Olyaei, Anthony Montanaro

Journal of Precision Respiratory Medicine · 2019

DOI: 10.2500/jprm.2019.190003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Precision Respiratory Medicine, 2019. Verfasst von Kevin Kron und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma is a heterogeneous inflammatory disease of the airway, characterized by airway hyperresponsiveness, airway obstruction, mucus hyperproduction, and airway-wall remodeling. Management of this disease involves the use of several types of therapeutic agents, each with unique indications based on the underlying cause of inflammation, clinical severity, and patient phenotype and/or endotype.

Objective

A review of the function, clinical utility, and safety of biologic agents in the management of allergic asthma. This particular asthma phenotype involves multiple cytokines in its pathogenesis, specifically those secreted by T-helper type 2 cells.

Methods

Medical literature was obtained from online biomedical archive searches from July 2018 to May 2019. An emphasis was placed on clinical trials that discussed biologic agents that target immunoglobulin E, interleukin (IL) 5, IL-4/IL-13, and chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) pathways involved in the expression of allergic asthma.

Results

The treatment options reviewed in this article were shown to be effective in targeting these pathways associated with allergic asthma. However, because these biologic agents are commonly prescribed in the treatment of severe asthma, many patients continue to experience asthma signs and symptoms.

Conclusion

Future clinical trials that study these agents should focus on ideal patient selection, dosing regimens, and cost-effectiveness in the management of asthma. Ideally, comparative trials should be undertaken to assist the clinician in choosing the optimal agent.

Zitieren

APA

Kron, K., Crow, M. J., Olyaei, A., & Montanaro, A. (2019). Biologic targeted therapy in allergic asthma. Journal of Precision Respiratory Medicine. https://doi.org/10.2500/jprm.2019.190003

Vancouver

Kron K, Crow MJ, Olyaei A, Montanaro A. Biologic targeted therapy in allergic asthma. Journal of Precision Respiratory Medicine. 2019. doi:10.2500/jprm.2019.190003

BibTeX
@article{Kron2019,
  author = {Kron, Kevin and Crow, Mason J. and Olyaei, Ali and Montanaro, Anthony},
  title = {Biologic targeted therapy in allergic asthma},
  journal = {Journal of Precision Respiratory Medicine},
  year = {2019},
  doi = {10.2500/jprm.2019.190003}
}
Kostenlos starten →